Apoptosis

Apoptosis(凋亡)

As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.

Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.

Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.

Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.

Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.

Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.

One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.

p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.

Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9). 

Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.

References:
1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.
2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.
3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.
4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.
5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.

研究方向

Apoptosis 相关产品(2721)

  • GC17045 structure
    GC17045AXL1717
    CAS: 477-47-4
    纯度: >99.50%

    AXL1717是一种具有口服活性和高效选择性的胰岛素样生长因子1受体(IGF-1R)抑制剂,IC 50 值为1nM。

  • GC17050 structure
    GC17050CYT387
    CAS: 1056634-68-4
    纯度: >98.50%

    A potent inhibitor of JAK1 and JAK2

  • GC17054 structure
    GC17054Thalidomide
    CAS: 50-35-1
    纯度: >99.50%

    Thalidomide是一种非成瘾性、非巴比妥类镇静剂,可抑制cereblon蛋白,具有抗炎和抗血管生成特性。

  • GC17057 structure
    GC17057Lithocholic Acid
    CAS: 434-13-9
    纯度: >98.00% / >99.50%

    A toxic secondary bile acid

  • GC17067 structure
    GC17067LDC000067
    CAS: 1073485-20-7
    纯度: >98.50%

    A Cdk9 inhibitor

  • GC17074 structure
    GC17074Tadalafil
    CAS: 171596-29-5
    纯度: >99.50%

    Tadalafil是一种有效、可逆且具有选择性的磷酸二酯酶5(PDE5)小分子抑制剂,IC 50 为1.8nM。Tadalafil还能够抑制PDE11(IC 50 为11nM)。

  • GC17094 structure
    GC17094Acitretin
    CAS: 55079-83-9
    纯度: >99.00%

    A retinoid

  • GC17096 structure
    GC17096STF-118804
    CAS: 894187-61-2
    纯度: >99.00%

    A Nampt inhibitor

  • GC17107 structure
    GC17107PluriSIn #1 (NSC 14613)
    CAS: 91396-88-2
    纯度: >99.50%

    A selective inhibitor of stearoyl-CoA desaturase

  • GC17119 structure
    GC171198-Prenylnaringenin
    CAS: 53846-50-7
    纯度: >99.00%

    A phytoestrogen

  • GC17121 structure
    GC17121Mycophenolic acid
    CAS: 24280-93-1
    纯度: >99.50%

    An immunosuppressive microbial metabolite

  • GC17167 structure
    GC17167SM-164
    CAS: 957135-43-2
    纯度: >99.50%

    A cell-permeable Smac mimetic

  • GC17195 structure
    GC17195Bax inhibitor peptide V5
    CAS: 579492-81-2
    纯度: >98.00%

    A Bax inhibitor

  • GC17198 structure
    GC17198Cycloheximide
    CAS: 66-81-9
    纯度: >98.00%

    环己酰亚胺是一种抗生素,它在翻译水平上抑制蛋白质合成,仅对真核细胞的细胞质(80s)核糖体起作用。

  • GC17214 structure
    GC17214PF-3758309
    CAS: 898044-15-0
    纯度: >98.50%

    PF-3758309是 ATP竞争性p21活化激酶4(PAK4)抑制剂,其Kd值为2.7nM,Ki值为18.7nM。

  • GC17240 structure
    GC17240Epothilone B (EPO906, Patupilone)
    CAS: 152044-54-7
    纯度: >99.00%

    Microtubule stabilizing agent

  • GC17255 structure
    GC17255Gliotoxin
    CAS: 67-99-2
    纯度: >98.00%

    Gliotoxin是一种由病原性曲霉菌等真菌产生的免疫抑制性霉菌毒素,是一种特异性的20S蛋白酶体糜蛋白酶活性抑制剂,IC 50 为10μM。

  • GC17262 structure
    GC17262Pifithrin-β
    CAS: 60477-34-1
    纯度: >98.00%

    An inactivator of p53

  • GC17276 structure
    GC17276Monomethyl auristatin E
    CAS: 474645-27-7
    纯度: >98.50%

    Monomethyl Auristatin E (MMAE),作为海兔毒素 10 的合成衍生物,海兔毒素 10 是一种线性五肽,最初是从海兔 Dolabella auriculari 的提取物中分离出来的。

  • GC17287 structure
    GC17287Iberin
    CAS: 505-44-2
    纯度: >98.00%

    A natural isothiocyanate

  • GC17303 structure
    GC17303Ritonavir
    CAS: 155213-67-5
    纯度: >99.50%

    An HIV protease inhibitor

  • GC17318 structure
    GC17318Orlistat
    CAS: 96829-58-2
    纯度: >98.00%

    奥利司他是胰脏和胃中脂肪酶的不可逆抑制剂,是治疗肥胖症的药物。

  • GC17331 structure
    GC17331Salubrinal
    CAS: 405060-95-9
    纯度: >99.50%

    Salubrinal是有效的选择性真核翻译起始因子2α(eIF2α)去磷酸化抑制剂。

  • GC17346 structure
    GC17346KT 5823
    CAS: 126643-37-6
    纯度: >95.00%

    Potent selective inhibitor of cGMP-dependent protein kinase (PKG)